Connection

Michelle Mello to Drug Industry

Back to Details
This is a "connection" page, showing publications Michelle Mello has written about Drug Industry.
Michelle Mello
Connection Strength
1.553
Drug Industry
  1. Disclosing Prescription-Drug Prices in Advertisements - Legal and Public Health Issues. N Engl J Med. 2018 Dec 13; 379(24):2290-2293.
    View in: PubMed
    Score: 0.420
  2. Drug Companies' Liability for the Opioid Epidemic. N Engl J Med. 2017 Dec 14; 377(24):2301-2305.
    View in: PubMed
    Score: 0.394
  3. Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies. BMJ Open. 2017 Dec 05; 7(12):e017917.
    View in: PubMed
    Score: 0.393
  4. Restrictions on the use of prescribing data for drug promotion. N Engl J Med. 2011 Sep 29; 365(13):1248-54.
    View in: PubMed
    Score: 0.253
  5. Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey. J Gen Intern Med. 2017 Jul; 32(7):767-774.
    View in: PubMed
    Score: 0.093
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.